Literature DB >> 20595150

Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma.

N L Smith1, D W Denning.   

Abstract

Chronic pulmonary aspergillosis (CPA) is a condition caused by the ubiquitous fungus Aspergillus fumigatus in non-immunocompromised individuals. Numerous underlying conditions have been associated with CPA. Details of the underlying conditions of 126 CPA patients attending our tertiary referral clinic from all over the UK were extracted from the clinical notes, and the distribution of these underlying conditions was analysed. For those with several underlying pulmonary conditions, one was nominated as the primary condition. Many patients presented with multiple underlying conditions, and a total of 232 underlying conditions were identified for the 126 patients. Previous classical tuberculosis and non-tuberculous mycobacterial infection were the most common primary underlying conditions (15.3% and 14.9%, respectively). Others included allergic bronchopulmonary aspergillosis (ABPA), chronic obstructive pulmonary condition (COPD) and/or emphysema, pneumothorax and prior treated lung cancer. Some conditions were found more often as one of multiple underlying conditions, while others were found only as secondary underlying conditions. Tuberculosis, non-tuberculous mycobacterial infection and ABPA remain the predominant risk factors for development of CPA, with COPD, prior pneumothorax or treated lung cancer also relatively common among our referrals. Many patients have multiple underlying pulmonary conditions. CPA should be considered when upper lobe cavitary or fibrotic disease and systemic symptoms are present in those with lung disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20595150     DOI: 10.1183/09031936.00054810

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  119 in total

1.  Azole antifungal resistance today: focus on Aspergillus.

Authors:  Paul Bowyer; Caroline B Moore; Riina Rautemaa; David W Denning; Malcolm D Richardson
Journal:  Curr Infect Dis Rep       Date:  2011-12       Impact factor: 3.725

2.  Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosis.

Authors:  David W Denning; Alex Pleuvry; Donald C Cole
Journal:  Bull World Health Organ       Date:  2011-09-27       Impact factor: 9.408

3.  Chronic necrotizing pulmonary aspergillosis in an immunocompetent patient: report of a rare case.

Authors:  E Jin; L M Wang; Q Y Li; X Feng; S L Ma
Journal:  Infection       Date:  2014-01-01       Impact factor: 3.553

4.  Pulmonary aspergillosis presenting with recurrent haemoptysis.

Authors:  Blas Y Betancourt; Adrian C Garofoli; Jagbir S Sandhu; Noella Boma; Alexander M Sy
Journal:  BMJ Case Rep       Date:  2015-07-07

5.  Prevalence of chronic pulmonary aspergillosis in patients with tuberculosis from Iran.

Authors:  M T Hedayati; Y Azimi; A Droudinia; B Mousavi; A Khalilian; N Hedayati; D W Denning
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-05-24       Impact factor: 3.267

6.  Chronic cavitating pulmonary aspergillosis with lung abscess.

Authors:  Kathryn Musgrave; Laura Succony; Reena Kotecha
Journal:  BMJ Case Rep       Date:  2012-07-18

Review 7.  Aspergillus Species in Bronchiectasis: Challenges in the Cystic Fibrosis and Non-cystic Fibrosis Airways.

Authors:  Sanjay H Chotirmall; Maria Teresa Martin-Gomez
Journal:  Mycopathologia       Date:  2017-05-17       Impact factor: 2.574

8.  Clinico-microbiological profile of chronic pulmonary aspergillosis from a tertiary care centre in southern India.

Authors:  Kiran Chawla; Kranthi Kosaraju; Sridevi Rayasam; Chiranjay Mukhopadhyay
Journal:  J Clin Diagn Res       Date:  2013-12-15

9.  Serious fungal infections in Peru.

Authors:  B Bustamante; D W Denning; P E Campos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-02-10       Impact factor: 3.267

10.  An invisible threat: mutation-mediated resistance to triazole drugs in Aspergillus.

Authors:  Cau D Pham; Shawn R Lockhart
Journal:  Curr Fungal Infect Rep       Date:  2012-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.